Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
Editorials & Other Articles
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
General Discussion
Related: Editorials & Other Articles, Issue Forums, Alliance Forums, Region ForumsHealth Officials Investigate Rare Form of Blindness Tied to Ozempic
People taking Ozempic and similar drugs may have to keep an eye out for an unexpected side effect. Health officials in Europe are looking into whether these diabetes and weight loss treatments could raise the risk of a rare but serious disorder that can cause blindness, following recent reports showing a possible association.
On Monday, the Danish Medicines Agency announced that it would ask health officials at the European Union to investigate if GLP-1 medications can potentially cause non-arteritic anterior ischemic optic neuropathy, or NAION. Studies this year from researchers in the U.S., and now Denmark, have suggested that GLP-1 users face a greater risk of NAION. At this point, however, its still not clear whether theres a causative link between the two, and the condition appears to be very rare even among GLP-1 users.
NAION is caused by a loss of blood flow to the optic nerve, which then results in sudden and often permanent vision loss. Not much is known about why it happens, though some likely risk factors include age, high blood pressure, and sleep apnea.
Ophthalmologists at Harvard Medical School and Mass Eye and Ear were the first scientists to publicly highlight the potential connection between NAION and GLP-1s. In July, they published a study showing that people taking semaglutide (the active ingredient in Ozempic and Wegovy) for their diabetes or obesity were more likely to develop NAION than similar patients taking other drugs over a three year period.
On Monday, the Danish Medicines Agency announced that it would ask health officials at the European Union to investigate if GLP-1 medications can potentially cause non-arteritic anterior ischemic optic neuropathy, or NAION. Studies this year from researchers in the U.S., and now Denmark, have suggested that GLP-1 users face a greater risk of NAION. At this point, however, its still not clear whether theres a causative link between the two, and the condition appears to be very rare even among GLP-1 users.
NAION is caused by a loss of blood flow to the optic nerve, which then results in sudden and often permanent vision loss. Not much is known about why it happens, though some likely risk factors include age, high blood pressure, and sleep apnea.
Ophthalmologists at Harvard Medical School and Mass Eye and Ear were the first scientists to publicly highlight the potential connection between NAION and GLP-1s. In July, they published a study showing that people taking semaglutide (the active ingredient in Ozempic and Wegovy) for their diabetes or obesity were more likely to develop NAION than similar patients taking other drugs over a three year period.
https://gizmodo.com/health-officials-investigate-rare-form-of-blindness-tied-to-ozempic-2000539752
6 replies
= new reply since forum marked as read
Highlight:
NoneDon't highlight anything
5 newestHighlight 5 most recent replies
Health Officials Investigate Rare Form of Blindness Tied to Ozempic (Original Post)
justaprogressive
Dec 17
OP
Like diabetes, use of drugs like Plaquenil for auto immune disease, high blood pressure, etc., an annual or more
Silent Type
Dec 17
#2
MissB
(16,120 posts)1. I know it is a popular drug and has some good effects but
I do always worry when drugs like this roll out. Inevitably side effects will show up later that give folks some pause.
Silent Type
(7,346 posts)2. Like diabetes, use of drugs like Plaquenil for auto immune disease, high blood pressure, etc., an annual or more
frequent eye exam will become the standard of care.
Wounded Bear
(60,849 posts)3. Diabetics already do this, or should. There are several potential eye disorders associated with diabetes...nt
Ritabert
(766 posts)6. Retinal hemorrhages for example
JCMach1
(28,149 posts)4. Ozempic had too many side effects for me...
I stopped after about 8 months.
Traildogbob
(10,202 posts)5. Damn
You finally lose the weight you want, are looking great and cant even see yourself.